Serum lysozyme levels in patients with solid tumors.

Letter: Serum lysozyme levels in Crohn's disease.

Bloodstream infections in patients with solid tumors.

Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum levels of lysozyme in term and preterm newborns.

Serum lysozyme levels in malignant histiocytosis of the intestine.

Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors.

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors.

Primary venous thromboembolism prophylaxis in patients with solid tumors.

Constitutional balanced translocations in patients with solid tumors.

Prognostic significance of HER3 in patients with malignant solid tumors.

Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumors.

Serum irisin levels in patients with psoriasis.

Serum CA19-9 in patients with solid pancreatic mass.

[Plasma fibrin monomer levels in patients with gynecologic tumors (proceedings)].

Cyclophosphamide in solid tumors.

Autotransplantation in solid tumors.

Solid tumors in children.

Serum Lysozyme (Muramidase) Levels in Intra-Abdominal Abscesses: An Experimental Study.

Serum and tissue lysozyme in leprosy.

Changes in serum desnutrin levels in patients with acne vulgaris.

Serum lysozyme in inflammatory bowel disease.

Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors.

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review.

Suggest Documents

Letter: Serum lysozyme levels in Crohn's disease.

Bloodstream infections in patients with solid tumors.

Letter: Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum levels of lysozyme in term and preterm newborns.

Serum lysozyme levels in malignant histiocytosis of the intestine.

Serum lysozyme levels in Crohn's disease and ulcerative colitis.

Serum parathyroid hormone-related protein concentrations in patients with hematologic malignancies or solid tumors.

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors.

Primary venous thromboembolism prophylaxis in patients with solid tumors.

Constitutional balanced translocations in patients with solid tumors.

Prognostic significance of HER3 in patients with malignant solid tumors.

Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumors.

Serum irisin levels in patients with psoriasis.

Serum CA19-9 in patients with solid pancreatic mass.

[Plasma fibrin monomer levels in patients with gynecologic tumors (proceedings)].

Cyclophosphamide in solid tumors.

Autotransplantation in solid tumors.

Solid tumors in children.

Serum Lysozyme (Muramidase) Levels in Intra-Abdominal Abscesses: An Experimental Study.

Serum and tissue lysozyme in leprosy.

Changes in serum desnutrin levels in patients with acne vulgaris.

Serum lysozyme in inflammatory bowel disease.

Phase I study of carboplatin in combination with PM00104 (Zalypsis®) in patients with advanced solid tumors.

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review.

Serum lysozyme levels in patients with solid tumors.

Recommend Documents

Follow Us